Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04769960 · ClinicalTrials.gov registry record

Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy

A clinical trial of Breast Cancer and Breast Neoplasms, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
68
Enrollment target
3
Study locations

NCT04769960: Active study of Breast Cancer and Breast Neoplasms, sponsored by Memorial Sloan Kettering Cancer Center.

NCT04769960 is a study of Breast Cancer and Breast Neoplasms that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 68 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04769960, a study of Breast Cancer and Breast Neoplasms, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
68 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to find out whether it is safe to perform MRI scans in people who have breast tissue expanders in place.

Primary Outcome

Our first aim is to assess the safety of imaging patients with breast tissue expanders in the MRI. Among the 50 MRI scans, if we can successfully complete at least 50, meaning that there are no issues of burning, heating, or pain in the region of the breast tissue expander that prevents the completion of the MRI, then we will declare the imaging safe and worthy of further investigation.

Interventions

  • DIAGNOSTIC_TEST MRI Studies
  • BEHAVIORAL Patient Reported Outcomes

Study Locations (3)

New York

  • Memorial Sloan Kettering Commack (Consent Only) - Commack
  • Memorial Sloan Kettering Cancer Center - New York

New Jersey

  • Memorial Sloan Kettering Bergen (Consent only ) - Montvale

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2021-02-19
Est. Completion 2026-02-19
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT04769960 still lists

NCT04769960 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which MRI Studies is the first listed.

NCT04769960 reports a single indexed study location in New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT04769960 about?

NCT04769960 is a clinical study titled "Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy". The purpose of this study is to find out whether it is safe to perform MRI scans in people who have breast tissue expanders in place.

What is the current status of trial NCT04769960?

This trial is currently active not recruiting. The enrollment target is 68 participants. The study started on 2021-02-19. Estimated completion is 2026-02-19.

What conditions does trial NCT04769960 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasms, Breast Adenocarcinoma.

What interventions are being tested in trial NCT04769960?

The interventions under investigation include: MRI Studies (DIAGNOSTIC_TEST), Patient Reported Outcomes (BEHAVIORAL).

Who is sponsoring clinical trial NCT04769960?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04769960 being conducted?

This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04769960's enrollment target sits among peer trials

68 706th of 1224 higher than 509 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04769960, the US trial registry maintained by the National Library of Medicine. NCT04769960 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.